Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;18(3):269-285.
doi: 10.1016/S1474-4422(18)30443-5. Epub 2019 Jan 21.

Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Collaborators

Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Multiple Sclerosis Collaborators. Lancet Neurol. 2019 Mar.

Abstract

Background: Multiple sclerosis is the most common inflammatory neurological disease in young adults. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic method of quantifying various effects of a given condition by demographic variables and geography. In this systematic analysis, we quantified the global burden of multiple sclerosis and its relationship with country development level.

Methods: We assessed the epidemiology of multiple sclerosis from 1990 to 2016. Epidemiological outcomes for multiple sclerosis were modelled with DisMod-MR version 2.1, a Bayesian meta-regression framework widely used in GBD epidemiological modelling. Assessment of multiple sclerosis as the cause of death was based on 13 110 site-years of vital registration data analysed in the GBD's cause of death ensemble modelling module, which is designed to choose the optimum combination of mathematical models and predictive covariates based on out-of-sample predictive validity testing. Data on prevalence and deaths are summarised in the indicator, disability-adjusted life-years (DALYs), which was calculated as the sum of years of life lost (YLLs) and years of life lived with a disability. We used the Socio-demographic Index, a composite indicator of income per person, years of education, and fertility, to assess relations with development level.

Findings: In 2016, there were 2 221 188 prevalent cases of multiple sclerosis (95% uncertainty interval [UI] 2 033 866-2 436 858) globally, which corresponded to a 10·4% (9·1 to 11·8) increase in the age-standardised prevalence since 1990. The highest age-standardised multiple sclerosis prevalence estimates per 100 000 population were in high-income North America (164·6, 95% UI, 153·2 to 177·1), western Europe (127·0, 115·4 to 139·6), and Australasia (91·1, 81·5 to 101·7), and the lowest were in eastern sub-Saharan Africa (3·3, 2·9-3·8), central sub-Saharan African (2·8, 2·4 to 3·1), and Oceania (2·0, 1·71 to 2·29). There were 18 932 deaths due to multiple sclerosis (95% UI 16 577 to 21 033) and 1 151 478 DALYs (968 605 to 1 345 776) due to multiple sclerosis in 2016. Globally, age-standardised death rates decreased significantly (change -11·5%, 95% UI -35·4 to -4·7), whereas the change in age-standardised DALYs was not significant (-4·2%, -16·4 to 0·8). YLLs due to premature death were greatest in the sixth decade of life (22·05, 95% UI 19·08 to 25·34). Changes in age-standardised DALYs assessed with the Socio-demographic Index between 1990 and 2016 were variable.

Interpretation: Multiple sclerosis is not common but is a potentially severe cause of neurological disability throughout adult life. Prevalence has increased substantially in many regions since 1990. These findings will be useful for resource allocation and planning in health services. Many regions worldwide have few or no epidemiological data on multiple sclerosis, and more studies are needed to make more accurate estimates.

Funding: Bill & Melinda Gates Foundation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-standardised multiple sclerosis prevalence per 100 000 population in 2016 for both sexes, by location ATG=Antigua and Barbuda. Isl=Islands. LCA=Saint Lucia. VCT=Saint Vincent and the Grenadines. TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micornesia.
Figure 2
Figure 2
Age-standardised prevalence of multiple sclerosis in 2016, by age and sex Shading shows 95% uncertainty intervals.
Figure 3
Figure 3
YLDs and YLLs due to multiple sclerosis in 2016, by age Shading shows 95% uncertainty intervals. YLDs=years lived with disability. YLLs=years of life lost.
Figure 4
Figure 4
Age-standardised DALYs for multiple sclerosis by SDI, 1990–2016, and expected value-based SDI The black line represents the average expected relationship between SDI and DALYs for multiple sclerosis based on values from all countries over the 1990–2016 estimation period. DALYs= disability-adjusted life-years. SDI=Socio-demographic Index.

Comment in

References

    1. Reich D, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018;378:169–180. - PMC - PubMed
    1. Belbasis L, Bellou V, Evangelou E. Environmental risk factors and multiple sclerosis, an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14:263–273. - PubMed
    1. Baranzini SE, Oksenberg JR. The genetics of multiple sclerosis. From 0 to 200 in 50 years. Trends Genet. 2017;33:960–970. - PMC - PubMed
    1. Palace J, Duddy M, Bregenzer T. Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Lancet Neurol. 2015;14:497–505. - PubMed
    1. Evans C, Beland SG, Kulaga S. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiol. 2013;40:195–210. - PubMed

Publication types